Document Detail


Randomized phase II study of clinical effects of ghrelin after esophagectomy with gastric tube reconstruction.
MedLine Citation:
PMID:  20096432     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Ghrelin is a peptide hormone with pleiotropic functions including stimulation of growth hormone secretion and appetite, and its levels decrease after esophagectomy. The aim of this study was to evaluate whether exogenous ghrelin administration can meliorate the postoperative decrease of oral food intake and body weight, which are serious complications after esophagectomy. METHODS: This prospective randomized, placebo-controlled, clinical trial assigned a total of 20 patients with thoracic esophageal cancer who underwent radical operation into either a ghrelin (n =10) or placebo (n =10) group. Synthetic human ghrelin (3 microg/kg) or 0.9% saline placebo was administered intravenously twice daily for 10 days from the day after the start of food intake. The primary end point was calories of food intake. Comparison of appetite and changes in weight and body composition were also made between the 2 groups. RESULTS: Intake of food calories was greater in ghrelin group than placebo group (mean 874 vs 605 kcal per day; P =.015). The appetite score tended to be greater in ghrelin group than placebo group (P =.094). Loss of weight was less in ghrelin group (-1% vs -3%; P =.019) and this attenuation was due largely to a decrease of lean body weight loss (0% vs -4%; P =.012). No side effects were observed in either groups. CONCLUSION: These preliminary results suggest that administration of ghrelin after esophagectomy increased oral food intake and attenuated weight loss together with maintenance of lean body weight.
Authors:
Kazuyoshi Yamamoto; Shuji Takiguchi; Hiroshi Miyata; Shinichi Adachi; Yuichiro Hiura; Makoto Yamasaki; Kiyokazu Nakajima; Yoshiyuki Fujiwara; Masaki Mori; Kenji Kangawa; Yuichiro Doki
Publication Detail:
Type:  Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial     Date:  2010-01-21
Journal Detail:
Title:  Surgery     Volume:  148     ISSN:  1532-7361     ISO Abbreviation:  Surgery     Publication Date:  2010 Jul 
Date Detail:
Created Date:  2010-06-15     Completed Date:  2010-07-01     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0417347     Medline TA:  Surgery     Country:  United States    
Other Details:
Languages:  eng     Pagination:  31-8     Citation Subset:  AIM; IM    
Copyright Information:
Copyright 2010 Mosby, Inc. All rights reserved.
Affiliation:
Division of Gastroenterological Surgery, Department of Surgery, Graduate School of Medicine, Osaka University, Osaka, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Body Composition
Energy Intake
Esophageal Neoplasms / surgery*
Esophagectomy* / adverse effects
Female
Ghrelin / blood,  therapeutic use*
Humans
Male
Middle Aged
Prospective Studies
Reconstructive Surgical Procedures / methods*
Stomach / surgery*
Weight Loss
Chemical
Reg. No./Substance:
0/Ghrelin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Does a positive lymphocyte cross-match contraindicate living-donor liver transplantation?
Next Document:  The utility of pre-operative peritoneal lavage examination in serosa-invading gastric cancer patient...